IRB Approves Additional Enrollment in Cellceutix's Clinical Trial of New Cancer Drug Candidate for Solid Tumors
May 22, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - May 22, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology,...
Cellceutix Reports Results for Quarter Ended March 31, 2015; Enrollment for Oral Mucositis Studies to Begin This Month
May 13, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - May 13, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Selects Independent Directors and Committee Members
April 27, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Apr 27, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Provides Corporate Update
April 21, 2015 10:05 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Apr 21, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology,...
Cellceutix PIND Meeting Scheduled With FDA for Hidradenitis Suppurativa
April 13, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Apr 13, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Enters Into a $30 Million Common Stock Purchase Agreement
April 01, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Apr 1, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology,...
Tenth Cohort Completed in Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin, No Adverse Events Reported
March 24, 2015 08:28 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Mar 24, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Advancing Treatment for Hidradenitis Suppurativa, Pre-IND Meeting Request to Food and Drug Administration
March 16, 2015 08:32 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Mar 16, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix to Expand Its Skin Product Pipeline
March 02, 2015 09:31 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Mar 2, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Enthusiastic About Proposed Budget Increase to $1.2 Billion to Fight Drug-Resistance Bacteria
January 27, 2015 10:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - Jan 27, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology...